Skip to content
Screener

Xenon Pharmaceuticals XENE Other Non-Current Liabilities

Other Non-Current Liabilities at other companies

Eli Lilly logo
Eli LillyLLY
$7.34B+213%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$10.1B-1.6%
Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
$161.5M+77.2%
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
$991K-47.1%
Biohaven logo
BiohavenBHVN
$4.56M-1.2%
Xencor logo
XencorXNCR
$152K—

Other financials

Income statement

See full
Revenue-—
Operating income-$123.2M-30.7%
Net income-$110.7M-30.7%
EPS (diluted)-$1.11-3.7%

Balance sheet

See full
Cash & equivalents$119.5M-11.7%
Total debt$6.4M-26.4%
Total equity$1.2B+96.0%
Total assets$1.3B+92.2%

Cash flow

See full
Operating cash flow-$95.4M-48.5%
CapEx$275.0K+75.2%
Free cash flow-$95.7M-48.6%

Valuation

See full
Market cap$6.24B+137%
Enterprise value$6.13B+145%

Profitability

See full
Operating margin-4,974.3%—
Net margin-4,612.1%—
FCF margin-3,732.2%—

Returns & leverage

See full
Return on equity-43.6%+8.2pp
Debt / equity0×0.0×
Current ratio21×+5.9×

Where this comes from

Reported directly by Xenon Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:OtherLiabilitiesNoncurrent.

The source filing: Xenon Pharmaceuticals’s 10-Q, filed August 6, 2026. Open the filing →

Filed
Aug 6, 2026, 4:31 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-338244

FAQ

What is Xenon Pharmaceuticals's other non-current liabilities?
Xenon Pharmaceuticals (XENE) reported other non-current liabilities of $3.29M in Q2 2026.
What does other non-current liabilities mean?
Miscellaneous long-term obligations not classified in specific categories — pension liabilities, environmental remediation, and other long-term accruals.

Ask your AI about Xenon Pharmaceuticals's other non-current liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude